Suppr超能文献

[经皮微波凝固治疗肝癌后超声引导下肿瘤床超抗原注射诱导的局部细胞免疫反应]

[Local cellular immune response induced by ultrasound-guided tumor bed superantigen injection after percutaneous microwave coagulation therapy for liver cancer].

作者信息

Han Xiu-jie, Dong Bao-wei, Liang Ping, Yu Xiao-ling, Yu De-jiang

机构信息

Department of Diagnostic Ultrasonography, Beijing Hospital, Beijing 100730, China.

出版信息

Zhonghua Zhong Liu Za Zhi. 2009 Aug;31(8):602-6.

Abstract

OBJECTIVE

To investigate the local cellular immune response after injection of superantigen, the highly agglutinative staphylococin (HAS), into the tumor bed after ultrasound-guided percutaneous microwave coagulation therapy (PMCT) in the liver cancer patients.

METHODS

Ninety-two patients with pathologically proven primary liver cancer were divided into two groups: 45 in group A were treated by PMCT alone and 47 in the group B by combined with ultrasound-guided percutaneous injection of highly agglutinative staphylococin (HAS). Before and after PMCT and HAS treatment, the patients underwent ultrasound-guided percutaneous biopsy from the tumor bed and the samples were examined by pathology and immunohistochemistry. The infiltration of CD3+, CD4+, CD57+ and CD68+ lymphocytes in treatment zone was compared between the two groups. Moreover, the infiltrating immunocytes were observed by transmission electron microscopy.

RESULTS

One week after HAS injection, the densities of CD3+, CD4+, CD57+ and CD68+ cells in the group B were 54.50 +/- 18.44, 38.14 +/- 12.44, 33.38 +/- 10.79 and 45.56 +/- 16.53, respectively. All the above mentioned parameters increased significantly in varying degrees compared with that before PMCT or HAS injection (P < 0.05). Four weeks after HAS injection, the density of CD3+, CD4+, CD57+ and CD68+ cells in the group B were 32.67 +/- 10.42, 23.43 +/- 6.99, 18.63 +/- 7.89 and 30.01 +/- 11.05, respectively, still significantly higher than those before PMCT (P < 0.05). Five weeks after PMCT and HAS injection, the densities of CD3+, CD4+, CD57+ and CD68+ cells in the group B were 54.50 +/- 18.44, 38.14 +/- 12.44, 33.38 +/- 10.79 and 45.56 +/- 16.53, versus 32.03 +/- 8.11, 15.67 +/- 8.32, 15.23 +/- 8.26 and 29.67 +/- 11.98 in the group A, respectively, still with a significant difference between the two groups (P < 0.05). A lot of lysosomes, endoplasmic reticulum and mitochondria in the immune cells after injection of HAS were observed by transmission electron microscopy.

CONCLUSION

The local cellular immunity in liver cancer treatment area can be significantly improved by ultrasound-guided injection of highly agglutinative staphylococin after percutaneous microwave coagulation therapy.

摘要

目的

探讨在肝癌患者经超声引导下经皮微波凝固治疗(PMCT)后,向肿瘤床注射超抗原——高聚集性葡萄球菌素(HAS)后的局部细胞免疫反应。

方法

92例经病理证实的原发性肝癌患者分为两组:A组45例仅接受PMCT治疗,B组47例接受超声引导下经皮注射高聚集性葡萄球菌素(HAS)联合PMCT治疗。在PMCT和HAS治疗前后,患者接受超声引导下经皮肿瘤床穿刺活检,样本进行病理和免疫组化检查。比较两组治疗区域CD3 +、CD4 +、CD57 +和CD68 +淋巴细胞的浸润情况。此外,通过透射电子显微镜观察浸润的免疫细胞。

结果

注射HAS后1周,B组CD3 +、CD4 +、CD57 +和CD68 +细胞密度分别为54.50±18.44、38.14±12.44、33.38±10.79和45.56±16.53。与PMCT或HAS注射前相比,上述所有参数均有不同程度的显著增加(P < 0.05)。注射HAS后4周,B组CD3 +、CD4 +、CD57 +和CD68 +细胞密度分别为32.67±10.42、23.43±6.99、18.63±7.89和30.01±11.05,仍显著高于PMCT前(P < 0.05)。PMCT和HAS注射后5周,B组CD3 +、CD4 +、CD57 +和CD68 +细胞密度分别为54.50±18.44、38.14±12.44、33.38±10.79和45.56±16.53,A组分别为32.03±8.11、15.67±8.32、15.23±8.26和29.67±11.98,两组仍有显著差异(P < 0.05)。透射电子显微镜观察发现,注射HAS后免疫细胞中有大量溶酶体、内质网和线粒体。

结论

经皮微波凝固治疗后,超声引导下注射高聚集性葡萄球菌素可显著改善肝癌治疗区域的局部细胞免疫。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验